JP2007507424A - 銀及び亜鉛を含むボディーケア剤 - Google Patents
銀及び亜鉛を含むボディーケア剤 Download PDFInfo
- Publication number
- JP2007507424A JP2007507424A JP2006524329A JP2006524329A JP2007507424A JP 2007507424 A JP2007507424 A JP 2007507424A JP 2006524329 A JP2006524329 A JP 2006524329A JP 2006524329 A JP2006524329 A JP 2006524329A JP 2007507424 A JP2007507424 A JP 2007507424A
- Authority
- JP
- Japan
- Prior art keywords
- particles
- care composition
- body care
- silver
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 99
- 239000004332 silver Substances 0.000 title claims abstract description 99
- 229910052725 zinc Inorganic materials 0.000 title claims description 26
- 239000011701 zinc Substances 0.000 title claims description 26
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title claims description 25
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 239000002245 particle Substances 0.000 claims abstract description 113
- 239000000203 mixture Substances 0.000 claims abstract description 86
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 71
- -1 silver ions Chemical class 0.000 claims abstract description 39
- 229910052751 metal Inorganic materials 0.000 claims abstract description 24
- 239000002184 metal Substances 0.000 claims abstract description 24
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000002923 metal particle Substances 0.000 claims abstract description 13
- 210000001124 body fluid Anatomy 0.000 claims abstract description 11
- 239000010839 body fluid Substances 0.000 claims abstract description 11
- 239000006071 cream Substances 0.000 claims description 31
- 239000003814 drug Substances 0.000 claims description 19
- 239000002674 ointment Substances 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- 239000011164 primary particle Substances 0.000 claims description 13
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 12
- 229910001431 copper ion Inorganic materials 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 229910052802 copper Inorganic materials 0.000 claims description 9
- 239000010949 copper Substances 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 239000000499 gel Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 206010061218 Inflammation Diseases 0.000 claims description 6
- 208000015181 infectious disease Diseases 0.000 claims description 6
- 230000004054 inflammatory process Effects 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 229920002545 silicone oil Polymers 0.000 claims description 6
- 230000035876 healing Effects 0.000 claims description 5
- 235000010446 mineral oil Nutrition 0.000 claims description 5
- 239000002480 mineral oil Substances 0.000 claims description 5
- BSWGGJHLVUUXTL-UHFFFAOYSA-N silver zinc Chemical compound [Zn].[Ag] BSWGGJHLVUUXTL-UHFFFAOYSA-N 0.000 claims description 5
- 229910001297 Zn alloy Inorganic materials 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 229910000881 Cu alloy Inorganic materials 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- NZWXMOTXTNDNLK-UHFFFAOYSA-N [Cu].[Zn].[Ag] Chemical compound [Cu].[Zn].[Ag] NZWXMOTXTNDNLK-UHFFFAOYSA-N 0.000 claims description 3
- 239000012876 carrier material Substances 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000000606 toothpaste Substances 0.000 claims description 3
- 206010021639 Incontinence Diseases 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 235000015218 chewing gum Nutrition 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 210000004209 hair Anatomy 0.000 claims description 2
- 239000002324 mouth wash Substances 0.000 claims description 2
- 239000004745 nonwoven fabric Substances 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 238000004544 sputter deposition Methods 0.000 claims description 2
- 230000000475 sunscreen effect Effects 0.000 claims description 2
- 239000000516 sunscreening agent Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 229940034610 toothpaste Drugs 0.000 claims description 2
- 238000012549 training Methods 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 229940051866 mouthwash Drugs 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 27
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 12
- 150000002500 ions Chemical class 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 231100000433 cytotoxic Toxicity 0.000 description 4
- 230000001472 cytotoxic effect Effects 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229960005150 glycerol Drugs 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000004438 BET method Methods 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229920002493 poly(chlorotrifluoroethylene) Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 239000005023 polychlorotrifluoroethylene (PCTFE) polymer Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920006324 polyoxymethylene Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 2
- 229920000874 polytetramethylene terephthalate Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229910001923 silver oxide Inorganic materials 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 208000011092 Hand injury Diseases 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920006292 Polyphenylene isophthalamide Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 229910052946 acanthite Inorganic materials 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052809 inorganic oxide Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920003366 poly(p-phenylene terephthalamide) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920002721 polycyanoacrylate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229940056910 silver sulfide Drugs 0.000 description 1
- XUARKZBEFFVFRG-UHFFFAOYSA-N silver sulfide Chemical compound [S-2].[Ag+].[Ag+] XUARKZBEFFVFRG-UHFFFAOYSA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Powder Metallurgy (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10340276A DE10340276B4 (de) | 2003-08-29 | 2003-08-29 | Körperpflegemittel mit Silber und Zink |
| PCT/EP2004/009534 WO2005023206A2 (de) | 2003-08-29 | 2004-08-26 | Körperpflegemittel mit silber und zink |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007507424A true JP2007507424A (ja) | 2007-03-29 |
| JP2007507424A5 JP2007507424A5 (enExample) | 2007-08-16 |
Family
ID=34223263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006524329A Withdrawn JP2007507424A (ja) | 2003-08-29 | 2004-08-26 | 銀及び亜鉛を含むボディーケア剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20070077312A1 (enExample) |
| EP (2) | EP1897593A2 (enExample) |
| JP (1) | JP2007507424A (enExample) |
| AT (1) | ATE425736T1 (enExample) |
| DE (2) | DE10340276B4 (enExample) |
| WO (1) | WO2005023206A2 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007504107A (ja) * | 2003-08-29 | 2007-03-01 | バイオ−ゲイト アーゲー | 多孔性銀粒子を含むボディーケア製品 |
| JP2011523677A (ja) * | 2008-05-05 | 2011-08-18 | ジャワハーラル ネール センター フォー アドヴァンスド サイエンティフィック リサーチ | テンプレートフリー及びポリマーフリーの金属ナノスポンジ、並びにその製造方法 |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10043151A1 (de) * | 2000-08-31 | 2002-03-28 | Peter Steinruecke | Knochenzement mit antimikrobieller Wirksamkeit |
| DE10146050B4 (de) * | 2001-09-18 | 2007-11-29 | Bio-Gate Ag | Verfahren zur Herstellung eines antimikrobiellen Kleb- und Beschichtungsstoffes |
| DE10205600B4 (de) * | 2002-02-11 | 2005-06-23 | Bio-Gate Bioinnovative Materials Gmbh | Saugfähiger Hygieneartikel zur Aufnahme von Körperflüssigkeit |
| US8734421B2 (en) | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
| KR20130090932A (ko) * | 2005-06-03 | 2013-08-14 | 프레자코르, 인크. | 원소 금속을 포함하는 조성물 및 그의 용도 |
| DE102006049108B4 (de) | 2006-10-13 | 2019-05-02 | Agxx Intellectual Property Holding Gmbh | Bioaktive, rutheniumhaltige Beschichtungen, deren Verwendung und Verfahren zur Beschichtung einer Vorrichtung |
| DE102007001466A1 (de) | 2007-01-10 | 2008-07-17 | S&B Industrial Minerals Gmbh | Verfahren zur Herstellung eines antibakteriell bzw. antimikrobiell wirkenden keramischen Werkstoffes sowie dessen Verwendung |
| GB2449893A (en) * | 2007-06-07 | 2008-12-10 | Aguacure Ltd | Antimicrobial composition |
| WO2009045720A2 (en) * | 2007-09-28 | 2009-04-09 | Johnson & Johnson Consumer Companies, Inc. | Electricity-generating particulates and the use thereof |
| DE102008031023A1 (de) | 2008-06-30 | 2009-12-31 | Neubourg Skin Care Gmbh & Co. Kg | Schaumhautpflegecreme |
| US20100082088A1 (en) * | 2008-08-27 | 2010-04-01 | Ali Fassih | Treatment of sweating and hyperhydrosis |
| EP2218447B1 (en) * | 2008-11-04 | 2017-04-19 | PharmaSol GmbH | Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles |
| DE102009006941B4 (de) * | 2009-01-30 | 2013-01-10 | Otto Bock Healthcare Gmbh | Verwendung von fein verteilten Metallpartikeln in einem Material, einer Hautauflage und einem orthopädischen Artikel |
| US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
| SG174922A1 (en) * | 2009-03-27 | 2011-11-28 | Ethicon Inc | Medical devices with galvanic particulates |
| DE202009007115U1 (de) * | 2009-05-18 | 2010-06-02 | Amoena Medizin-Orthopädie-Technik GmbH | Brustprothese |
| ES2607493T3 (es) | 2009-05-26 | 2017-03-31 | The General Hospital Corporation | Aparato para el suministro dérmico de una sustancia |
| DE202009016573U1 (de) | 2009-12-08 | 2010-03-04 | Schermuly, Helmut | Dermale, antimikrobielle Fußcreme |
| KR20110091461A (ko) * | 2010-02-05 | 2011-08-11 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | 갈바니 미립자를 포함하는 립 조성물 |
| CN102781406B (zh) * | 2010-03-01 | 2015-07-08 | 强生消费者公司 | 具有理想的整体颜色的护肤组合物 |
| US20110236491A1 (en) * | 2010-03-25 | 2011-09-29 | Jeannette Chantalat | Topical anti-inflammatory composition |
| DE102010030546A1 (de) | 2010-06-25 | 2011-01-05 | Lr Health And Beauty Systems Gmbh | Zahnpflegekaugummi mit Silberanteilen |
| DE102011121687A1 (de) | 2011-12-14 | 2013-06-20 | Gmbu E.V., Fachsektion Dresden | Verfahren zur Abscheidung von Silber und danach abgeschiedenes Silber |
| US9381588B2 (en) | 2013-03-08 | 2016-07-05 | Lotus BioEFx, LLC | Multi-metal particle generator and method |
| US10905894B2 (en) | 2013-03-15 | 2021-02-02 | Prezacor, Inc. | Therapeutic bioelectromagnetic fields, pain relief devices, and related methods |
| CN107399507B (zh) * | 2017-09-06 | 2019-10-22 | 云南中烟工业有限责任公司 | 一种延长袋装口含烟货架期的方法 |
| NL2019490B1 (en) * | 2017-09-06 | 2019-03-14 | Nuud B V | Deodorant composition |
| US20200383883A1 (en) * | 2017-09-06 | 2020-12-10 | Nuud B.V. | Deodorant composition |
| GB2595304A (en) * | 2020-05-22 | 2021-11-24 | Copper Clothing Ltd | Antimicrobial material |
| DE102023132061A1 (de) | 2023-11-17 | 2025-05-22 | TROVOcare GmbH & Co. KG | Glaspulver mit erhöhten Metallionen-Freisetzungsraten unterschiedlicher Metallionen-Kombinationen zum schnelleren Vermindern von Mikroorganismen und/oder Viren und zum Unterstützen einer Zellregeneration und/oder -proliferation und Verfahren zum Herstellen solcher Glaspulver |
| CN121015697A (zh) * | 2024-07-12 | 2025-11-28 | 陕西科技大学 | 一种滴眼液及其制备方法及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4828832A (en) * | 1983-09-07 | 1989-05-09 | Laboratorios Biochemie De Mexico | Method of manufacturing a composition for treating skin lesions |
| US5268174A (en) * | 1988-09-29 | 1993-12-07 | Kabushiki Kaisha Sangi | Antimicrobial hydroxyapatite powders containing hinokitiol, protamine or sorbic acid |
| US5009898A (en) * | 1988-09-29 | 1991-04-23 | Kabushiki Kaisha Sangi | Antimicrobial hydroxyapatite powders and methods for preparing them |
| JPH04170960A (ja) * | 1990-11-06 | 1992-06-18 | Sangi Co Ltd | 抗菌性ハイドロキシアパタイト |
| GB9502253D0 (en) * | 1995-02-06 | 1995-03-29 | Giltech Ltd | The effects of antibacterial agents on the behaviour of mouse fibroblasts in vitro |
| US5744151A (en) * | 1995-06-30 | 1998-04-28 | Capelli; Christopher C. | Silver-based pharmaceutical compositions |
| US6123925A (en) * | 1998-07-27 | 2000-09-26 | Healthshield Technologies L.L.C. | Antibiotic toothpaste |
| EP1066825A1 (en) * | 1999-06-17 | 2001-01-10 | The Procter & Gamble Company | An anti-microbial body care product |
| JP2001151681A (ja) * | 1999-11-24 | 2001-06-05 | Lintec Corp | 消化器系疾患の予防および／または治療剤 |
| DE10043151A1 (de) * | 2000-08-31 | 2002-03-28 | Peter Steinruecke | Knochenzement mit antimikrobieller Wirksamkeit |
| JP2002179514A (ja) * | 2000-12-11 | 2002-06-26 | Nisshin Steel Co Ltd | 抗菌剤，抗菌剤の製造方法及び抗菌性樹脂組成物 |
| DE10141117A1 (de) * | 2001-08-22 | 2003-03-13 | Schott Glas | Antimikrobielles Silicatglas und dessen Verwendung |
-
2003
- 2003-08-29 DE DE10340276A patent/DE10340276B4/de not_active Expired - Lifetime
-
2004
- 2004-08-26 AT AT04764510T patent/ATE425736T1/de not_active IP Right Cessation
- 2004-08-26 JP JP2006524329A patent/JP2007507424A/ja not_active Withdrawn
- 2004-08-26 EP EP07020782A patent/EP1897593A2/de not_active Withdrawn
- 2004-08-26 EP EP04764510A patent/EP1658040B1/de not_active Expired - Lifetime
- 2004-08-26 WO PCT/EP2004/009534 patent/WO2005023206A2/de not_active Ceased
- 2004-08-26 DE DE502004009182T patent/DE502004009182D1/de not_active Expired - Lifetime
- 2004-08-26 US US10/569,709 patent/US20070077312A1/en not_active Abandoned
-
2010
- 2010-02-26 US US12/714,251 patent/US20100151032A1/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007504107A (ja) * | 2003-08-29 | 2007-03-01 | バイオ−ゲイト アーゲー | 多孔性銀粒子を含むボディーケア製品 |
| JP2011523677A (ja) * | 2008-05-05 | 2011-08-18 | ジャワハーラル ネール センター フォー アドヴァンスド サイエンティフィック リサーチ | テンプレートフリー及びポリマーフリーの金属ナノスポンジ、並びにその製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| DE502004009182D1 (de) | 2009-04-30 |
| EP1658040A2 (de) | 2006-05-24 |
| WO2005023206A2 (de) | 2005-03-17 |
| DE10340276A1 (de) | 2005-03-31 |
| DE10340276B4 (de) | 2006-11-09 |
| EP1897593A2 (de) | 2008-03-12 |
| ATE425736T1 (de) | 2009-04-15 |
| US20100151032A1 (en) | 2010-06-17 |
| US20070077312A1 (en) | 2007-04-05 |
| EP1658040B1 (de) | 2009-03-18 |
| WO2005023206A3 (de) | 2005-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4731480B2 (ja) | 多孔性銀粒子を含むボディーケア製品 | |
| JP2007507424A (ja) | 銀及び亜鉛を含むボディーケア剤 | |
| US6720006B2 (en) | Anti-microbial body care product | |
| US6093414A (en) | Silver-based antimicrobial compositions | |
| US6358516B1 (en) | One-step system for cleansing, conditioning, and treating the skin | |
| AU735373B2 (en) | Silver-based antimicrobial compositions | |
| US6932976B2 (en) | Enzyme blocking skin protectant cream | |
| JP2002020218A (ja) | 皮脂吸着性粉体及びその使用 | |
| MXPA06015143A (es) | Composiciones antimicrobianas y metodos de uso de las mismas. | |
| EP1061899B1 (en) | Liquid antimicrobial, skin moisturizing formulation | |
| KR100877739B1 (ko) | 다공성 은 입자를 함유하는 바디 케어 제품 | |
| Babickaite et al. | Therapeutic activity of chlorhexidine-poloxamer antiseptic gel on wound healing in rats: a preclinical study | |
| HK1114803A (en) | Bodycare product with silver and zinc | |
| HK1096303A (en) | Body care product containing porous silver particles | |
| WO2001078659A1 (fr) | Lotions laiteuses, preparations cosmetiques, agents de nettoyage de la peau et articles de nettoyage de la peau | |
| KR20180031513A (ko) | 금 나노 입자가 도포된 기능성 기저귀, 생리대 및 그 제조방법 | |
| Ojo et al. | Mupirocin/hydroxyapatite composite suspended in transcutol P-spiked hydrogel: In vitro characterization and in vivo wound healing assessment | |
| CA2383742C (en) | Silver-based antimicrobial compositions | |
| JP2000344654A (ja) | 化粧品パック料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070629 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070629 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20100301 |